«Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases» has been accepted for publication in Alzheimer’s & Dementia. This work was supported in part by JPND through the DEMTEST project, selected in the 2011 biomarkers call.
noviembre 24, 2016